SDAMLO

LaunchSM

amlodipine

NDAORALFOR SOLUTION
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT06236061Phase 3Completed

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Started Apr 2024
718 enrolled
Hypertension
NCT03205137N/AWithdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Started Jun 2022
0
Hypertension
NCT06713785Phase 4Withdrawn

Personalised Electronic Record Supported Optimisation of Amlodipine for Patients With Hypertension

Started Sep 2020
NCT03226275Phase 1Completed

Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese Participants

Started Aug 2017
32 enrolled
Healthy
NCT02969265Phase 3Withdrawn

An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential Hypertension

Started May 2017
0
Hypertension